Drreddys Laboratories | RDY - Actif À Court Terme





Actif À Court Terme Changement Date
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Aurora Cannabis CAD 445.84M 22M 2025-12
Bayer EUR 32.91B 30M 2025-12
Canopy Growth CAD 524.67M 78.85M 2025-12
Cipla INR 249.18B 16.3B 2025-09
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Drreddys Laboratories INR 3.31B 164.26M 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lonza CHF 8B 3.41B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pacira USD 547.97M 14.78M 2025-12
Phibro Animal Health USD 862.18M 26.39M 2025-12
Prestige Brands USD 433.43M 63.98M 2025-12
Richter Gedeon HUF 772.16B 39.24B 2025-12
Sun Pharmaceuticals INR 601.36B 75.42B 2025-09
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12